SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sean Janzen who wrote (1195)2/26/1999 9:51:00 PM
From: Harold Lehman  Read Replies (1) of 1501
 
Sean,

Thanks a lot. That was a great find. I think it's just a matter of time before good things happen for all of us. Cortecs has to soon make their decision, if they haven't already, about whether they are going to go forward with the development of the tb antigen test. I know, from someone I spoke with in Cortecs in December, that they are interested in it, but they had management turmoil and may have spread themselves too thin. I actually think that Inflazyme would make a lot more from this test if they could get it back, with much of the later developmental work already having been done. And, hopefully, they'll have the preclinical studies of IPL 576,089 ready to be submitted to the regulatory agencies by March's end. Combine this with market conditions swinging in our favor and I feel like this company could be unstoppable.

Adios,
Harold
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News